Emerging data suggest Retatrutide , a dual agonist targeting both GLP-1 and glucose-dependent insulinotropic polypeptide , appears to offer a significant development for obesity management . Preliminary https://bookmarkforce.com/story21544070/a-retatrutide-peptide-a-innovation-in-weight-regulation